RCAMU
Rothschild & Co Asset Management US’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.68M | Sell |
418,929
-31,948
| -7% | -$204K | 0.04% | 218 |
|
|
2022
Q3 | $4.32M | Sell |
450,877
-33,145
| -7% | -$318K | 0.07% | 192 |
|
|
2022
Q2 | $5.34M | Sell |
484,022
-24,673
| -5% | -$272K | 0.08% | 172 |
|
|
2022
Q1 | $8.47M | Sell |
508,695
-120,918
| -19% | -$2.01M | 0.11% | 155 |
|
|
2021
Q4 | $12M | Buy |
629,613
+95,526
| +18% | +$1.82M | 0.14% | 161 |
|
|
2021
Q3 | $13.2M | Sell |
534,087
-59,667
| -10% | -$1.47M | 0.16% | 151 |
|
|
2021
Q2 | $15.4M | Buy |
593,754
+75,218
| +15% | +$1.96M | 0.18% | 148 |
|
|
2021
Q1 | $16.4M | Sell |
518,536
-244,887
| -32% | -$7.75M | 0.2% | 143 |
|
|
2020
Q4 | $35.4M | Sell |
763,423
-145,864
| -16% | -$6.77M | 0.46% | 60 |
|
|
2020
Q3 | $29.9M | Sell |
909,287
-54,597
| -6% | -$1.8M | 0.54% | 55 |
|
|
2020
Q2 | $26.5M | Buy |
963,884
+47,175
| +5% | +$1.29M | 0.39% | 95 |
|
|
2020
Q1 | $27.4M | Buy |
916,709
+640,349
| +232% | +$19.2M | 0.43% | 87 |
|
|
2019
Q4 | $7.65M | Buy |
+276,360
| New | +$7.65M | 0.08% | 268 |
|